XML 29 R18.htm IDEA: XBRL DOCUMENT v3.8.0.1
Corrections to Previously Issued Consolidated Financial Statements (Tables)
9 Months Ended
Jun. 30, 2017
Corrections to Previously Issued Consolidated Financial Statements [Abstract]  
Schedule of corrections and consolidated financial statements

    As of and for the Period Ended
June 30, 2016
 
ITEMS   Previously 
Reported
    Adjustments     Restated  
                   
Consolidated Statements of Balance Sheets                        
Prepayment     3,500,000       (3,500,000 )     -  
Due to related party     -       6,500,000       6,500,000  
Accumulated deficit     (669,207 )     (10,000,000 )     (10,669,207 )
                         
Consolidated Statements of Operations and Comprehensive Loss                        
For the nine months ended June 30, 2016                        
Research and development expenses     -       10,000,000       10,000,000  
Net Loss     (352,796 )     (10,000,000 )     (10,352,796 )
Basic and diluted loss per share     (0.00 )     (0.05 )     (0.05 )
                         
Consolidated Statements of Cash Flow                        
Net loss from operating activities     (353,605 )     (10,000,000 )     (10,353,605 )
Issuance of common stock for compensation     -       897,521       897,521  
(Increase) decreases in prepayment     (3,496,185 )     3,500,000       3,815  
(Increase) decrease in due from related party     350,000       (350,000 )     -  
Increase (decrease) in due to related party     (22,517 )     6,500,000       6,477,483  
Increase (decrease) in due to shareholder     (46,586 )     46,586       -  
Net cash used in operating activities     (3,857,447 )     594,107       (3,263,340 )
                         
(Increase) decrease in due to shareholder     -       (46,586 )     (46,586 )
Proceeds from subscription receivable     -       350,000       350,000  
Proceeds from issuance of common stock     897,521       (897,521 )     -  
Net cash used in financing activities     2,947,521       (594,107 )     (2,353,414 )

 

ITEMS   As of and for the Three and Nine Months Ended June 30, 2017  
    Previously 
Reported
    Adjustments     Restated  
                   
Consolidated Balance Sheets                  
Additional paid-in-capital     10,586,464       160,000       10,746,464  
Accumulated deficit     (11,848,288 )     (160,000 )     (12,008,288 )
Consolidated Statements of Operations                              
For the three months ended June 30, 2017                        
Revenues     90,000       (90,000 )     -  
Gross profit     90,000       (90,000 )     -  
Net loss from operations     (99,479 )     (90,000 )     (189,479 )
Loss from continuing operations before income taxes     (127,879 )     (90,000 )     (217,879 )
Net loss     (127,879 )     (90,000 )     (217,879 )
For the nine months ended June 30, 2017                        
Revenues     160,000       (160,000 )     -  
Gross profit     160,000       (160,000 )     -  
Net loss from operations     (476,706 )     (160,000 )     (636,706 )
Loss from continuing operations before income taxes     (524,057 )     (160,000 )     (684,057 )
Net loss     (524,887 )     (160,000 )     (684,887 )
Consolidated Statements of Cash Flow                              
For the nine months ended June 30, 2017                        
Cash flows from operating activities                        
Net loss from continuing operations     (524,887 )     (160,000 )     (684,887 )
Net cash used in operating activities     (1,115,484 )     (160,000 )     (1,275,484 )
Cash flows from financing activities                        
Capital contribution from related parties under common control     -       160,000       160,000  
Net cash provided by financing activities     950,000       160,000       1,110,000  

 

As a result of the restatement of the consolidated

Schedule of adjustments on previously reported consolidated financial statements
  Previously 
Reported on Form 10K
  Adjustments No.1  Adjustments No.2  Restated 
             
Consolidated Balance Sheet            
As of September 30, 2016                
Due to related party  -   6,500,000   -   6,500,000 
Total Liabilities  56,470   6,500,000   -   6,556,470 
Additional paid-in capital  4,733,401   -   60   4,733,461 
Accumulated deficit  (4,823,401)  (6,500,000)  -   (11,323,401)
Total equity (deficit)  120,882   (6,500,000)  -   (6,379,118)
                 
Consolidated Statements of Operations and Comprehensive Loss                
For the year ended September 30, 2016                
Selling, general and administrative expenses  4,497,263   (3,500,060)  60   997,263 
Research and development expenses  -   10,000,000   -   10,000,000 
Net loss from operations  (4,497,295)  (6,499,940)  (60)  (10,997,295)
Loss from continuing operations before income taxes  (4,506,963)  (6,499,940)  (60)  (11,006,963)
Net Loss  (4,507,799)  (6,499,940)  (60)  (11,007,799)
Basic and diluted loss per share  (0.00)  (0.06)  (0.00)  (0.06)
Consolidated Statements of Cash Flow                

For the year ended September 30, 2016

                
Net loss from continuing operations  (4,507,799)  (6,499,940)  (60)  (11,007,799)
Issuance of common stock for compensation  1,295,324   (60)  60   1,295,324 
(Decrease) increase in due to related party  (22,517)  6,500,000       6,477,483 
                 

Consolidated Statements of Cash Flow

                
For the year ended September 30, 2015                
Net cash used in operating activities  (517)    -   (198)  (715)